Skip to main content
. 2020 Mar 17;33(1):12–18. doi: 10.1089/ped.2019.1109

Table 3.

Cell-Mediated Effector Immunity

Type 1 CD4+ TH1 cells, CD8+ Tc1 cells, group 1 ILCs, NK cells
Type 2 CD4+ TH2 cells, CD8+ Tc2 cells, group 2 ILCs
Type 3 CD4+ TH17 cells, CD8+ Tc17 cells, group 3 ILCs

Annunziato et al.9

ILCs, innate lymphoid cells.